Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Extracorporeal Photopheresis With UVADEX in the Setting of a Standard Myeloablative Conditioning Regimen for the Prevention of Graft-versus-Host Disease in Patients Undergoing an Allogeneic Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

NCT00054600 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT00054600
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00054600 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Extracorporeal Photopheresis With UVADEX in the Setting of a Standard Myeloablative Conditioning Regimen for the Prevention of Graft-versus-Host Disease in Patients Undergoing an Allogeneic Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
Lead sponsor
Mallinckrodt
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2002
Completion date
June 30, 2004
Enrollment
60
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host disease